Expression of epigenetic pathway related genes in association with PD-L1, ER/PgR and MLH1 in endometrial carcinoma
The distribution of Endometrial Cancer (EC)-related deaths is uneven among the morphologic subtypes of EC. Serous Cancer (SC) makes 10% of all EC and accounts for 40% of EC-related deaths. We investigated expression of selected genes involved in epigenetic pathways by immunohistochemistry in a cohor...
Main Authors: | Ozlen Saglam, Biwei Cao, Xuefeng Wang, Gokce A. Toruner, Jose R. Conejo-Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884513/?tool=EBI |
Similar Items
-
Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer—An Immunohistochemical Assessment
by: Stanisław Przewoźny, et al.
Published: (2024-02-01) -
Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
by: Patil AV, et al.
Published: (2011-04-01) -
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
by: Barbara Tagliaferri, et al.
Published: (2020-09-01) -
KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
by: Ozlen Saglam, et al.
Published: (2020-01-01) -
Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
by: Tashima Rumiko, et al.
Published: (2011-10-01)